Older News:
February 2017: Phase 2 Clinical Trial Success for Anugel(™)
A randomised clinical trial has just completed in on 110 patients, found that Anugel(™) cuts the need for analgesics following surgery to remove Class 3 and 4 haemorrhoids, by 33% and reduces pain as measured on the VAS scale by 60%. Anugel(™) delivers a huge improvement in patient comfort. Details of the trials are being submitted for publication in major journals.
August 2016: QA Certified to ISO 9001:2015 and ISO 14001:2015
TUV Rheinland has certified Deep Life Medical Lda to ISO 9001:2015 and ISO 14001:2015. Deep Life Medical is in the process of obtaining ISO EN 13485 certification for its Anugel product, to complete with the ongoing clinical trials of the product.